|
|
|
|
|
|
|
|
And the progress being made is costly. Take, for instance, the use of Avastin to slow the growth of ovarian tumors by about four months — at a cost of around $72,000.
“Many would not consider this cost effective for the gain seen,” said Dr Elizabeth A. Eisenhauer of the Canada's National Cancer Institute, according to the New York Times.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.